• 
• 
• 
• 
• 
• 

Press Releases

1. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome

Presentations

1. Human primary chondrocytes, a relevant model of MPS IVA, internalize GALNS (N-Acetylgalactosamine-6-Sulfatase) into lysosomes, resulting in clearance of keratan sulfate